# The Effect of Alpha Lipoic Acid on the Incidence and Severity of Radiotherapy-Induced Oral Mucositis in Head and Neck Cancer Patients

> **NCT05023863** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 70 (estimated)

## Conditions studied

- Radiation-Induced Mucositis

## Interventions

- **DRUG:** Alpha Lipoic Acid 600 MG Oral Tablets
- **OTHER:** Placebo tablets
- **RADIATION:** radiation or concurrent chemoradiation

## Key facts

- **NCT ID:** NCT05023863
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-01
- **Primary completion:** 2022-05
- **Final completion:** 2022-08
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2021-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05023863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05023863, "The Effect of Alpha Lipoic Acid on the Incidence and Severity of Radiotherapy-Induced Oral Mucositis in Head and Neck Cancer Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05023863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*